Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Exelixis
Arcus Biosciences, Inc.
City of Hope Medical Center
M.D. Anderson Cancer Center
Dana-Farber Cancer Institute
City of Hope Medical Center
M.D. Anderson Cancer Center
Yale University
Thomas Jefferson University
Incyte Corporation
Agenus Inc.
Xencor, Inc.
City of Hope Medical Center
Mirati Therapeutics Inc.
Osel, Inc.
Abramson Cancer Center at Penn Medicine
OHSU Knight Cancer Institute
Bristol-Myers Squibb
Washington University School of Medicine
Bristol-Myers Squibb
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Alden Cancer Therapy II
Threshold Pharmaceuticals
Prostate Oncology Specialists, Inc.
Bristol-Myers Squibb
National Cancer Institute (NCI)
Amsterdam UMC, location VUmc